Digvijay Singh has written to the Union Health Minister demanding a CBI inquiry into drug trials in government medical colleges in Madhya Pradesh which has allegedly led to loss of 100 lives.
Singh has gone onto accuse the state government of “protecting” the concerned doctors. In a second letter, Digvijay Singh has charged the state government of being involved in a fake admission racket through which 700 students were admitted to MBBS courses.
"....A huge scandal has taken place in government medical colleges of Madhya Pradesh, where unsuspecting patients were made to undergo drug trials in which more than 100 people have lost their lives," Singh said in his letter. Adding that doctors in these medical colleges have made huge sums (of money), flouting all rules and regulations.
With Congress making a desperate bid to come to power in the upcoming Assembly polls, political observers say that such attacks will only escalate. The Congress is fervently hoping that Chouhan will be confronted with a two term anti-incumbency. The party has appointed young face Jyotiraditya Scindia as campaign committee chief for the November 25 polls.
In what is being described as a bid to “discredit” the BJP chief minister’s rule, Digvijay Singh has even drawn a direct link between the fake admission and the chief minister’s residence, alleging that several phone calls were made to the Chief Minister's residence during the examination.
Challenging the chief minister to turn the probe over to the CBI, Digvijay Singh has demanded that this “large scale corruption” needs a central probe.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)